Heidi Hagen

Track

Insider profile

Currently holds positions in Alaunos Therapeutics Inc and Vericel Corp

Positions

Position Company Period
Director Alaunos Therapeutics Inc June 13, 2019 -
Independent Director Vericel Corp Jan. 1, 2017 -
Director Vericel Corp Aug. 23, 2013 - Jan. 1, 2017
Heidi Hagen's trades of Vericel Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Vericel Corp (VCEL)
Transaction date
Planned sale
Price
422.86
Quantity 34,244 +31.0%
Value US$729,462
US Vericel Corp (VCEL)
Transaction date
Proposed sale
Price
334.23
Quantity 98,774
Value US$2,386,003
US Vericel Corp (VCEL)
Transaction date
Planned sale
Price
370.87
Quantity 47,545 +24.1%
Value US$2,507,897
US Vericel Corp (VCEL)
Transaction date
Proposed sale
Price
51.20
Quantity 9,000
Value US$460,800
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-25 2026-03-23
US Vericel Corp (VCEL)
PlS Planned sale
34,244 +31.0%
422.86
US$729,462 		34,244 +31.0% 422.86 US$729,462
2026-03-23 2026-03-23
US Vericel Corp (VCEL)
PrS Proposed sale
98,774
334.23
US$2,386,003 		98,774 334.23 US$2,386,003
2025-03-05 2025-03-03
US Vericel Corp (VCEL)
PlS Planned sale
47,545 +24.1%
370.87
US$2,507,897 		47,545 +24.1% 370.87 US$2,507,897
2025-03-03 2025-03-03
US Vericel Corp (VCEL)
PrS Proposed sale
9,000
51.20
US$460,800 		9,000 51.20 US$460,800